NCT03760185View on ClinicalTrials.gov

Pupil Dilation for Treatment of IFIS

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 4, 2019

Primary Completion Date

September 25, 2020

Study Completion Date

September 25, 2020

Conditions
Intraoperative Floppy Iris Syndrome
Interventions
DRUG

Brimonidine Tartrate

All subjects will apply brimonidine tartrate to one eye (right eye) only for the duration of study participation.

Trial Locations (1)

80204

Denver Health, Denver

All Listed Sponsors
lead

Denver Health and Hospital Authority

OTHER

NCT03760185 - Pupil Dilation for Treatment of IFIS | Biotech Hunter | Biotech Hunter